Cargando…
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
Autores principales: | Georgiadis, A., Duran, Y., Ribeiro, J., Abelleira-Hervas, L., Robbie, S. J., Sünkel-Laing, B., Fourali, S., Gonzalez-Cordero, A., Cristante, E., Michaelides, M., Bainbridge, J. W. B., Smith, A. J., Ali, R. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328849/ https://www.ncbi.nlm.nih.gov/pubmed/30046128 http://dx.doi.org/10.1038/s41434-018-0031-x |
Ejemplares similares
-
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
por: Georgiadis, A, et al.
Publicado: (2016) -
Severe Loss of Tritan Color Discrimination in RPE65 Associated Leber Congenital Amaurosis
por: Kumaran, Neruban, et al.
Publicado: (2018) -
A Cross-Sectional and Longitudinal Study of Retinal Sensitivity in RPE65-Associated Leber Congenital Amaurosis
por: Kumaran, Neruban, et al.
Publicado: (2018) -
Novel RPE65 mutations associated with Leber congenital amaurosis in Chinese patients
por: Xu, Fei, et al.
Publicado: (2012) -
A Gene Scan Study of RPE65 in Chinese Patients with Leber Congenital Amaurosis
por: Liu, Jing, et al.
Publicado: (2017)